These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 30850484)

  • 1. qPSMA: Semiautomatic Software for Whole-Body Tumor Burden Assessment in Prostate Cancer Using
    Gafita A; Bieth M; Krönke M; Tetteh G; Navarro F; Wang H; Günther E; Menze B; Weber WA; Eiber M
    J Nucl Med; 2019 Sep; 60(9):1277-1283. PubMed ID: 30850484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial Experience with Volumetric
    Schmuck S; von Klot CA; Henkenberens C; Sohns JM; Christiansen H; Wester HJ; Ross TL; Bengel FM; Derlin T
    J Nucl Med; 2017 Dec; 58(12):1962-1968. PubMed ID: 28522740
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Schmidkonz C; Cordes M; Schmidt D; Bäuerle T; Goetz TI; Beck M; Prante O; Cavallaro A; Uder M; Wullich B; Goebell P; Kuwert T; Ritt P
    Eur J Nucl Med Mol Imaging; 2018 Oct; 45(11):1862-1872. PubMed ID: 29725716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Semi-automatic evaluation of baseline whole-body tumor burden as an imaging biomarker of
    Zou Q; Jiao J; Zou MH; Li MZ; Yang T; Xu L; Zhang Y
    Abdom Radiol (NY); 2020 Dec; 45(12):4202-4213. PubMed ID: 32948911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semiautomatically Quantified Tumor Volume Using
    Seifert R; Herrmann K; Kleesiek J; Schäfers M; Shah V; Xu Z; Chabin G; Grbic S; Spottiswoode B; Rahbar K
    J Nucl Med; 2020 Dec; 61(12):1786-1792. PubMed ID: 32332147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 68Ga-PSMA-11 PET/CT derived quantitative volumetric tumor parameters for classification and evaluation of therapeutic response of bone metastases in prostate cancer patients.
    Schmidkonz C; Cordes M; Goetz TI; Prante O; Kuwert T; Ritt P; Uder M; Wullich B; Goebell P; Bäuerle T
    Ann Nucl Med; 2019 Oct; 33(10):766-775. PubMed ID: 31338731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of thresholding methods for the quantification of [
    Kim M; Seifert R; Fragemann J; Kersting D; Murray J; Jonske F; Pomykala KL; Egger J; Fendler WP; Herrmann K; Kleesiek J
    Eur J Nucl Med Mol Imaging; 2023 Jun; 50(7):2196-2209. PubMed ID: 36859618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection Threshold and Reproducibility of
    Lückerath K; Stuparu AD; Wei L; Kim W; Radu CG; Mona CE; Calais J; Rettig M; Reiter RE; Czernin J; Slavik R; Herrmann K; Eiber M; Fendler WP
    J Nucl Med; 2018 Sep; 59(9):1392-1397. PubMed ID: 29602819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matched-Pair Comparison of
    Rauscher I; Krönke M; König M; Gafita A; Maurer T; Horn T; Schiller K; Weber W; Eiber M
    J Nucl Med; 2020 Jan; 61(1):51-57. PubMed ID: 31253741
    [No Abstract]   [Full Text] [Related]  

  • 11. Tumor Sink Effect in
    Gafita A; Wang H; Robertson A; Armstrong WR; Zaum R; Weber M; Yagubbayli F; Kratochwil C; Grogan TR; Nguyen K; Navarro F; Esfandiari R; Rauscher I; Menze B; Elashoff D; Delpassand ES; Herrmann K; Czernin J; Hofman MS; Calais J; Fendler WP; Eiber M
    J Nucl Med; 2022 Feb; 63(2):226-232. PubMed ID: 34049987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [
    Xie Y; Li C; Zhang L; Zang S; Yu F; Wang S; Wang F
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Aug; 42(8):1143-1148. PubMed ID: 36073212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of early imaging with
    Özülker F
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019; 38(2):100-105. PubMed ID: 30514659
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Basha MAA; Hamed MAG; Hussein O; El-Diasty T; Abdelkhalek YI; Hussein YO; Alasamer AF; Mohamed HAE; Deen DSE; Tantawy EF; Metwally MI; Zaitoun MMA; Aly SA; Altohamy JI; Mohamed AEM; Afifi AHM; Harb O
    Abdom Radiol (NY); 2019 Jul; 44(7):2545-2556. PubMed ID: 30963182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection Efficacy of Hybrid
    Einspieler I; Rauscher I; Düwel C; Krönke M; Rischpler C; Habl G; Dewes S; Ott A; Wester HJ; Schwaiger M; Maurer T; Eiber M
    J Nucl Med; 2017 Jul; 58(7):1081-1087. PubMed ID: 28209912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 68Ga-PSMA PET/CT Detects the Location and Extent of Primary Prostate Cancer.
    Fendler WP; Schmidt DF; Wenter V; Thierfelder KM; Zach C; Stief C; Bartenstein P; Kirchner T; Gildehaus FJ; Gratzke C; Faber C
    J Nucl Med; 2016 Nov; 57(11):1720-1725. PubMed ID: 27261520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeatability of Quantitative
    Jansen BHE; Cysouw MCF; Vis AN; van Moorselaar RJA; Voortman J; Bodar YJL; Schober PR; Hendrikse NH; Hoekstra OS; Boellaard R; Oprea-Lager DE
    J Nucl Med; 2020 Sep; 61(9):1320-1325. PubMed ID: 31924729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EBONI: A Tool for Automated Quantification of Bone Metastasis Load in PSMA PET/CT.
    Hammes J; Täger P; Drzezga A
    J Nucl Med; 2018 Jul; 59(7):1070-1075. PubMed ID: 29242401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of whole-body tumor burden with
    Brito AET; Mourato FA; de Oliveira RPM; Leal ALG; Filho PJA; de Filho JLL
    Ann Nucl Med; 2019 May; 33(5):344-350. PubMed ID: 30746599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilot study comparing dominant intraprostatic lesion volume using Ga-68 prostate-specific membrane antigen PET-computed tomography and multiparametric MRI.
    Sasidharan A; Murthy V; Natarajan A; Agarwal A; Ranagrajan V; Gudi S; Singh S; Popat P
    Nucl Med Commun; 2020 Dec; 41(12):1291-1298. PubMed ID: 32941400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.